AbCellera Biologics Inc (NASDAQ: ABCL) is -51.66% lower on its value in year-to-date trading and has touched a low of $2.34 and a high of $6.05 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABCL stock was last observed hovering at around $2.72 in the last trading session, with the day’s gains setting it 0.04%.
Currently trading at $2.76, the stock is -0.90% and 2.78% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.8 million and changing 1.47% at the moment leaves the stock -19.71% off its SMA200. ABCL registered -37.70% loss for a year compared to 6-month loss of -28.31%. The firm has a 50-day simple moving average (SMA 50) of $2.6854 and a 200-day simple moving average (SMA200) of $3.437675.
The stock witnessed a 2.22% gain in the last 1 month and extending the period to 3 months gives it a 2.60%, and is 4.15% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.64% over the week and 6.22% over the month.
AbCellera Biologics Inc (ABCL) has around 586 employees, a market worth around $827.20M and $32.96M in sales. Profit margin for the company is -533.32%. Distance from 52-week low is 18.20% and -54.42% from its 52-week high. The company has generated returns on investments over the last 12 months (-15.36%).
with sales reaching $7.58M over the same period.The EPS is expected to shrink by -15.13% this year, but quarterly earnings will post -16.95% year-over-year. Quarterly sales are estimated to shrink -17.62% in year-over-year returns.
AbCellera Biologics Inc (ABCL) Top Institutional Holders
203.0 institutions hold shares in AbCellera Biologics Inc (ABCL), with institutional investors hold 53.06% of the company’s shares. The shares outstanding are 290.82M, and float is at 221.52M with Short Float at 7.51%. Institutions hold 38.21% of the Float.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 27.53 million shares valued at $81.48 million. The investor’s holdings represent 9.4033% of the ABCL Shares outstanding. As of 2024-06-30, the second largest holder is BAILLIE GIFFORD & CO with 21.91 million shares valued at $64.86 million to account for 7.4852 of the shares outstanding. The other top investors are VOYA INVESTMENT MANAGEMENT LLC which holds 10.63 million shares representing 3.6322% and valued at over $31.47 million, while CAPITAL WORLD INVESTORS holds 1.817 of the shares totaling 5.32 million with a market value of $15.74 million.
AbCellera Biologics Inc (ABCL) Insider Activity
#####
